Centessa Pharmaceuticals plc — DEFA14A Filings
4 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Centessa Pharmaceuticals plc (CNTA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Centessa Pharmaceuticals plc has filed 4 DEFA14A documents with the SEC since 2021. To view all SEC filings by Centessa Pharmaceuticals plc, see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001999371-25-006737 | May 28, 2025 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001999371-24-006363 | May 21, 2024 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001839882-23-013352 | May 23, 2023 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001839882-22-012798 | Jun 9, 2022 | — |